Expression of cyclooxygenase-2 in prostate carcinoma

Cancer

Volumn 89, Issue 3, 2000, Pages 589-596

  Yoshimura, Rikio ^a,d   Sano, Hajime ^b   Masuda, Chikayosi ^a   Kawamura, Masaki ^a   Tsubouchi, Yasunori ^b   Chargui, Jamel ^a   Yoshimura, Norio ^b   Hla, Timothy ^c   Wada, Seiji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cyclooxygenase 1; Cyclooxygenase 2; Immunohistochemistry; Prostate carcinoma

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

AGED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0034254972     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000801)89:3<589::AID-CNCR14>3.0.CO;2-C     Document Type: Article

References (60)

1. Colorectal cancer risk, chronic illness, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study
2. Aspirin use and reduced risk of fatal colon cancer
3. A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of the large-bowel cancer
4. Aspirin use, cancer, and polyps of the large bowel
5. Reduced risk of large-bowel adenomas among aspirin users
6. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals
7. Treatment of colonic and rectal adenoma with sulindac in familiar adenomatous polyposis
8. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment
9. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment
10. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitro samine
11. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, α-difluoromethylornithine, 16α-fluoro-5-androsten-17-one, and ellagic acid individually and in combination
12. A protective effect of sulindac against chemically-induced primary colonic tumors in mice
13. Dose-related inhibition of colon carcinogenesis by dietary piroxican, and nonsteroidal antiinflammatory drugs during different stages of rat colon tumor development
14. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues
15. Prostaglandin endoperoxide synthase: Structure and catalysis
16. Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells
17. Multiple cyclooxygenase: Cloning of a mitogen-inducible form
18. Concentration of prostaglandin endoperoxide synthase and prostaglandin I2 synthase in the endothelium and smooth muscle of bovine aorta
19. Immunohistochemical localization of prostaglandin forming cyclooxygenase in renal cortex
20. CDNA cloning and functional activity of a tory cyclooxygenase
21. Human cyclooxygenase-2 cDNA
22. Cyclooxygenase- 1 and -2 expression in rheumatoid synovial tissues: Effects of interleukin-1b, phorbol ester, and corticosteroids
23. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence
24. Human platelet/erythroleukemia cell prostaglandin G/H synthetase: cDNA cloning, expression, and gene chromosomal assignment
25. Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis: Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription
26. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
27. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas
28. Expression of cyclooxygenase-2 in human gastric carcinoma
29. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
30. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation
31. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
32. Cyclooxygenase-2 expression in human esophageal carcinoma
33. Cyclooxygenase-2 expression in up-regulated in human pancreatic cancer
34. NSAIDs, Cox-2 inhibitors, and the gut
35. Induction of prostaglandin G/H synthase in a canine model of spontaneous prostatic adenocarcinoma
36. Corticotropin-releasing hormone in clonic mucosa in patients with ulcerative colitis
37. Local secretion of corticotropin-releasing hormone by enterochromaffin cells in human colon
38. Microvessel quantitation and prognosis in invasive breast carcinoma
39. Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma
40. The heparin-binding (fibroblast) growth factor family of proteins
41. Transforming growth factor-βs; chemistry, biology and therapeutics
42. Transforming growth factor-beta in rheumatoid arthritis
43. Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthriticrats
44. Role of the early gene cytooxygenase (Cox)-2 in angiogenesis
45. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
46. A serum and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein
47. Selective expression of mitogen-inducible cyclooxygenase in macrophage stimulated with lipopolysaccharide
48. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer
49. High grade prostatic intraepithelial neoplasia: The most likely precursor of prostatic cancer
50. Prostatic intraepithelial neoplasia in surgical resections
51. The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma
52. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
53. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
54. Proliferative inflammatory atrophy of the prostate implications for prostatic carcinogenesis